Pillstats
Rx only · Tablet, Orally Disintegrating · Oral

Lamotrigine

Brands: Lamictal Odt · Lamotrigine

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US40 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers8 labelers
Packages61
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 24 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.28$2.57$3.85$5.14Dec 2025Apr 2026Jul 2026
$3.684
Latest avg · Jul 22, 2026
-17%
Since Dec 17, 2025
8
Active US suppliers
46%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7.0K14K21K28K2025 Q12025 Q22025 Q32025 Q42026 Q1
23K
Rx · 2026 Q1
2.0M
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown16SUPPLYING
Torrent Pharmaceuticals Limitedunknown12SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown8SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown8SUPPLYING
Dr.Reddy's laboratories Limitedunknown5SUPPLYING
GlaxoSmithKline LLCunknown4SUPPLYING
Ajanta Pharma USA Inc.unknown4SUPPLYING
Par Health USA, LLCunknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.